Replies to post #792331 on NorthWest Biotherapeutics Inc (NWBO)

[KevGee59]

That's a lot of words to try and convince me that the 2 things you described are comparable...they're not.

You're one of the most respected posters on this board...including me. But you missed this one. Just own it...move on...we all make mistakes.

Best wishes

JMHO...

[ilovetech]

Doc Logic -

"Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work"

Maybe we will finally see @business do an article on $NWBO soon??

"A broad reevaluation of dosing has the potential to benefit hundreds of thousands of people in developing countries who otherwise wouldn’t… pic.twitter.com/bDFcrlQsTy

— kristen shaughnessy (@kshaughnessy2) September 25, 2025

"Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work"

Maybe we will finally see @business do an article on $NWBO soon??

"A broad reevaluation of dosing has the potential to benefit hundreds of thousands of people in developing countries who otherwise wouldn’t be able to afford the drugs.

One obstacle has stood in the way: the drugmakers themselves.

Paid per dose, they stand to lose billions of dollars if doctors prescribe less medicine to their patients.

Bristol declined to assist doctors conducting trials of lower-dose Opdivo in India, doctors say there; they ended up getting the medication from other sources, such as charities. 

Merck went so far as to eliminate smaller vials of Keytruda, effectively requiring hospitals to use more than might be needed.

Used to treat melanoma and many other forms of cancer, Keytruda is now the best-selling drug of any kind in the world, with $29.5 billion in sales last year...."